The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Aquestive Therapeutics, Inc. insider acquisitions

Company CIK 0001398733 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
AQST · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Boyd Peter E.Boyd Peter E.Davis Matthew W.Davis Matthew W.Jung CassieJung CassieBoyd Peter E. · December 4, 2025 · Stock award · Common StockDavis Matthew W. · November 10, 2025 · Stock award · Non-Qualified Stock Option (right to buy)Davis Matthew W. · November 10, 2025 · Stock award · Common StockJung Cassie · October 15, 2025 · Exercise / conversion · Common StockOct 15, 2025Dec 4, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 4, 2025Aquestive Therapeutics, Inc.Common StockBoyd Peter E.Stock award
Nov 10, 2025Aquestive Therapeutics, Inc.Non-Qualified Stock Option (right to buy)Davis Matthew W.Stock award
Nov 10, 2025Aquestive Therapeutics, Inc.Common StockDavis Matthew W.Stock award
Oct 15, 2025Aquestive Therapeutics, Inc.Common StockJung CassieExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

AQST · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Boyd Peter E.Chief People Officer
Stock awardCommon StockNon-derivative security · Code A20,0000Value: 0Currency not specifiedView ↗
Trade:
Davis Matthew W.Chief Development Officer
Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A50,0000Value: 0Currency not specifiedView ↗
Trade:
Davis Matthew W.Chief Development Officer
Stock awardCommon StockNon-derivative security · Code A50,0000Value: 0Currency not specifiedView ↗
Trade:
Jung CassieChief Operating Officer
Exercise / conversionCommon StockNon-derivative security · Code M25,0003.1027Value: 77,567.5Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →